Hi QuanQuest,
Its been a very busy day fathoming data. Some of it not so good. First , yesterday we were told that the AZ vaccine has a 10.4% efficacy range in Covid 19 South African variant. That has taken some research to gain that the variant is mimicking the adaptive immune system and that due to this younger people are now getting infected as the acquired immune system is not recognising the system. It’s like it’s a reverse of the original Wuhan virus, where “ old “ people were getting an immune overload, but it’s now the younger generation. So, the vaccine that is engineered to recognising the pathogen , doesn’t seem to be efficacious in this variant. Yes, it’s complex.
Ref. ( as per yesterday’s post )
Secondly, two new other variants are at bay. E484Q and L452R both found recently in India, whereby the spike protein has changed shape to make it a better fit, and again its evading our immune system immediately, therefore gaining a solid foot hold in our body
Ref: “ What’s the new coronavirus variant in India and how should it change their response “ 2021.
Onto, the good news. Monepantel and it’s metabolised mate goes onto Organoid testing. The date we have gained is a tad better than WEHI or 360 Laboratories. But, what thrills me and certain other large parties is that . 1. The testing stays at Leiden and 2. This is a precursor for other patents to be organoid tested. This compound is being asked to do the Olympics and so far it and Leiden have excelled. Remember this is an ultra marathon. Not a 100 metre sprint.
So, the big news data , is that the Covid 19 can have as many variants as it is engineered with, and our Compound will kill the virus. I have told everyone on HC before the scientific data on why it does negate said Virus.
Now, in relation to your question, and thanks for the opportunity to explain.
PAA announcement and graphs. Logarithmic scale is based on powers which were used in the old days.
Example Log 100 is 2, Log 1000 is 3. In this instance it is depicting a large area of the graph in a compact way, because it would take “forever” to display Log 1 to 6 let’s say.
So, Graph A is Log 1 , incremental dose ages ( whatever they are, because we have no value) were placed against Covid 19 Vero 6 cells, there was 8 dose ages , the values range within as you can see in Dose 2 , 40 to 18% with an average of 25%, so low dose-age doesn’t help us v Covid. If we look at dose 6 it’s value ranges from 45 to 70% with an average of 60%. The higher dose ages don’t help us at all.
So does Monepantel efficacy rate with Covid 19, no not much, not enough to commercialise.
But, Graph B says it is very worthy of commercialisation, as it is the metabolite of Monepantel that will take on and cure Covid. So, we have 8 dose ages. Look at dose 7 which is excellent with a range of 75 to 85% and an average of 83%. But, dose 8 is the goal kicker, a range of 78 to 96% with an average of 93%.
This is as good as Pfizer or Moderna vaccine effectiveness in the Laboratory.
In relation to the cross reference of the controlled uninfected cells ( the green line ) , I am not sure, what value they were being controlled against. Another PAA enigma. We have lots of them.
I will ask others in relation to the “ green line “ and get back to you QuanQuest.
Expand
(20min delay)